md-medicaldata


Go to content

DENTAL TREATMENT AND ORAL MANIFESTATIONS IN MENOPAUSE

LEČENJE ZUBA I STANJE U USNOJ DUPLJI U MENOPAUZI

Authors

 

Milan Knezevic1, Gordana Andjelic2, Araceli Gamallo3, Milena Knezevic4

1 Faculty of Medicine and Public Health Sciences ULPGC, Hospital Universitario Insular, Las Palmas, Spain,
2 Instiitute for Medical Research, Military Medical Academy, Belgrade, Serbia,
3 Medical Center Guanarteme Las Palmas, Medicina Interna, Las Palmas, Spain,
4 Milena Knezevic BS, Faculty of Medicine and Public Health Sciences ULPGC, Las Palmas Spain

 

• The paper was received on 28.10.2015./ Accepted on 15.11.2915.

 

Abstract

 

Menopause is a physiological process typically occurring in the fifth decade of life in women, and involving permanent cessation of menstruation. Menopause is the consequence of hormonal changes that produce a series of general manifestations that have become increasingly important as a result of the increased female life expectancy in the industrialized world; indeed, such manifestations are observed throughout the last third of the female lifetime. However, oral symptoms are also found in addition to the more general manifestations of menopause (i.e., hot flush and psychological alterations). In this sense, an increased incidence of dry mouth (xerostomia), disorders such as lichen planus, benign pemphigoid, Sjogren's syndrome and burning mouth syndrome are observed, as well as a debated rise in the prevalence of periodontal disease.
The dental treatment of such patients involves a series of particularities that should be taken into account, including the use of salivary secretion stimulators or saliva substitutes in cases of hyposialosis. Nevertheless, correct prevention, with good control of bacterial plaque, contributes to reduce the risk of many infections within the oral cavity.

 

 

References

 

  1. Botella J. La edad crftica. Climaterio y menopausia. Barcelona: Salvat Editores 1990.
  2. Gonzalez J. Ginecologia. Barcelona: Masson 1997.
  3. Rebar RW. Discussion. Am J Obstet Gynecol 1987; 156: 1294-8.
  4. Tiegs RD, Body JJ, Wanner HW. Calcitonin secretion in postmenopausal osteoporosis. N Engl J Med 1985; 312: 109-10.
  5. Golay A, Shi ZMZ, Chiou YAM. HDL metabolism in non-insulin dependent diabetes. J Clin Endocrinol Metab 1987; 65: 512-8.
  6. Haspels AA, Musaph H. Psychosomatics in the perimenopause. Lancaster: MTP Press 1979. 25.  Ship JA, Patton LL, Tylenda CA. An assessment of salivary function in healthy premenopausal and postmenopausal females. J Gerontol 1991; 46:5-11.
  7. Kannel W, Hjortland MC, Mc Namara PM, Gordon T. Menopause and risk of cardiovascular disease. The Framingham Study. Ann Intern Med 1976;85:447-50.
  8. Bungay GT, Vessey MP, Mc Pherson CK. Study of symptoms in middle-life with special reference to the menopause. Br Med J 1980; 2: 181-3.
  9. Utian WH. Plasma estrogens and climacteric symptoms. Lancet 1978; 1: 1099-101.
  10. Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis. JAMA 1941; 116: 2465-74.
  11. Stumph WE. Mahdabananda S, Joshi SG. Oestrogen target cells in the skin. Experientia 1974; 30: 196-200.
  12. Riggs BL, Melton LJ. Evidence of two distinct syndromes of involutional osteoporosis. Am J Med 1983; 75: 899-901.
  13. Anderson E, Hamburguer S, Liu JH, Rebar RW. Characteristics of postmenopausal women seeking assistance. Am J Obstet Gynecol 1987; 156: 428-33.
  14. Karafin LJ, Coll ME. Lower urinary tract disorders in the postmenopausal woman. Med Clin North Am 1987; 71: 111-21.
  15. Zakrzewska JM. Women as dental patients: Are there any gender differences? Int Dent J 1996; 46: 548-57.
  16. Regezi JA, Sciubba J. Patologia bucal. Mexico : Interamericana S.A. Mc Graw-Hill Editores 1995.
  17. HanekeE. Glossodynia. HNO 1982; 30: 208-12.
  18. Kelly, Levin RP. Glossodynia. J Md State Dent Assoc 1986; 29: 23-8.
  19. Trikkas G, Nicolatou O, Samara C, Bazopoulou-Kyrkanidou E, Rabavilas AD, Christodoulou GN. Glossodynia: Personality, characteristics and psychopathology. Psychoter Psychosom 1996; 65: 163-8.
  20. Wardrop RW, Hailes J, Burger H, Reade PC. Oral discomfort at menopause. Oral Surg Oral Med Oral Pathol 1989; 67: 535-40.
  21. Volpe A, Lucenti V, Forabosco A. Oral discomfort and hormone replacement therapy in the post-menopause. Maturitas 1991; 13: 1-5.
  22. Forabosco A, Crisciiolo M, Coukos G. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 1992; 73: 570-4.
  23. Ben-Aryeh Ft, Miron D, Szargel R. Whole saliva secretion rates in old and young healthy subjects. J Dent Res 1984; 63: 1147-8. Bruce D, Rymer J. Symptoms of the menopause. Best Pract Res Obstet Gynaecol. 2009;23:25–32. [PubMed]
  24. Parvinen T, Parvinen I, Larmas M. Stimulated salivary flow rate, pH and lactobacillus and yeast concentration in medicated persons. Scand J Dent Res 1984; 92: 524-32.
  25. Ship JA, Patton LL, Tylenda CA. An assessment of salivary function in healthy premenopausal and postmenopausal females. J Gerontol 1991; 46:5-11.
  26. Ben Aryeh H, Gottlieb I, Ish Shalom S, David A, Szargel H, Laufer D. Oral complaints related to menopause. Maturitas 1996; 24: 185-9.
  27. Bullon P, Machuca G. La atencion odontologica en pacientes medica-mente comprometidos. Madrid: Torreangulo-Laboratorios Normon Editores 1996.
  28. Von Wowern N, Klausen B, Kollerup G. Osteoporosis: A risk factor in periodontal disease. J Periodontol 1994; 65: 1134-8.
  29. Hildebolt CF, Pilgram TK, Dotson M. Attachment loss with postmenopausal age and smoking. J Periodont Res 1997; 32: 619-625.
  30. Hildebolt CF, Pilgram TK, Yokoyama-Crothers N, Vannier MW, Dotson M, Muckerman J, et al. Alveolar bone height and postcranial bone mineral density: negative effects of cigarette smoking and parity. J Periodont 2000;71:683-9.
  31. Wactawski-Wende J, Grossi SG, Trevisan M. The role of osteopenia in oral bone loss and periodontal disease. J Periodontol 1996; 67: 1076-84.
  32. Elders PJM, Habets LLMH, Netelembos JC, Van Der Linden LWJ, Van Der Stelt PR The relation between periodontitis and systemic bone mass in women between 46 and 55 years of age. J Clin Periodontol 1992; 19: 492-6.
  33. Klemetti E, Collin HL, Forss H, Markkanen H, Lassila V Mineral status of skeleton and advanced periodontal disease. J Clin Periodontol 1994; 21: 184-8.
  34. Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontits in postmenopausal women. J Periodontol 2000; 71: 1492-8.
  35. Shrout MK, Hildebolt CF, Potter BJ, Brunsden TK, Pilgram TK, Dotson M, et al. Comparison of morphological meassurements extracted from digita-lized dental radiographs with lumbar and femoral bone mineral density meassurements in postmenopausal women. J Periodontol 2000; 71: 335-40.
  36. Reinhardt RA, Payne JB, Maze CA, Patil KD, Gallagher SJ, Mattson JS. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. J Periodontol 1999; 70: 823-8.
  37. Pilgram TK, Hildebolt CF, Yokoyama-Crothers N, Dotson M, Cohen SC, Hauser JF, et al. Relationships between radiographic alveolar bone height and probing attachment level: data fron healthy post-menopausal women. J Clin Periodontol 2000; 27: 341-6.
  38. Minsk L, Poison AM. Dental implant outcomes in postmenopausal women undergoing hormone replacement. Compend Contin Educ Dent 1998; 19: 859-62.
  39. Pisantry S, Rafaely B, Pilish UKW. The effect of steroid hormones in the buccal mucosa of menopausal women. Oral Surg Oral Med Oral Pathol 1975;40:346-53.
  40. Machuca G, Bullon P. Valoracion y tratamiento de la enfermedad periodontal en el anciano. En: Bullon P, Velasco E. Odontoestomatologia geriatrica. Madrid: IM&C Editores 1996.
  41. Bruce D, Rymer J. Symptoms of the menopause. Best Pract Res Obstet Gynaecol. 2009; 23: 25–32. [PubMed]
  42. Lopez BC, Perez MG, Soriano YJ. Dental considerations in pregnancy and menopause. J Clin Exp Dent 2011; 3:e135–44.
  43. Greenberg MS, Glick M, Ship JA. Burket's Oral Medicine. 11th ed. Hamilton: BC Decker Inc; 2008.
  44. Chiramana S, Ashok K. Examination, diagnosis and treatment planning for complete denture therapy: A review. J Orofac Sci 2010; 2: 29–35.
  45. Imirzalioglu P, Yuzugullu B, Gulsahi A. Correlation between residual ridge resorption and radio morphometric indices. Gerodontology 2012; 29(2): e536-42. doi: 10.1111/j.1741-2358.2011.00514.x. Epub 2011 Jul 19.
  46. Buencamino MC, Palomo L, Thacker HL. How menopause affects oral health, and what we can do about it. Cleveland Clin J Med 2009; 76: 467–75.
  47. Portillo GM. Oral manifestations and dental treatment in menopause. Med Oral. 2002;7:31–5.
  48. Paganini-Hill A. Hormone therapy and oral health. Menopause Manage. 2007: 31–40.
  49. Steinberg BJ. Women's oral health issues. J California Dent Assoc. 2000;28:663–7
  50. Friedlander AH. The physiology, medical management and oral implications of menopause. J Am Dent Assoc. 2002;133:73–81.

PDF Knezevic M. et al. • MD-Medical Data 2015;7(4): 295-300

Naslovna | Revija | Galerija | Dešavanja | Instrukcije | Redakcija | Izdavač | Prijatelji sajta | Saradnja | Kontakt | Site Map


Back to content | Back to main menu